TCIM
LPCN icon

TIAA CREF Investment Management’s Lipocine LPCN Stock Holding History

TIAA CREF Investment Management’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,006
Closed -$199K – 3160
2017
Q1 		$199K Sell
3,006
-128
-4% -$8.3K ﹤0.01% 2996
2016
Q4 		$196K Sell
3,134
-70
-2% -$4.43K ﹤0.01% 3046
2016
Q3 		$243 Hold
3,204
– – ﹤0.01% 3028
2016
Q2 		$166K Buy
+3,204
New +$496K ﹤0.01% 3110

Other funds holding LPCN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TIAA CREF Investment Management's LPCN Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of Lipocine (LPCN) in Q2 2017, closing a stake of 3,006 shares — an estimated $199K sold.

TIAA CREF Investment Management first reported a position in LPCN in Q2 2016 and held it in 4 quarters. The position peaked at $199K in Q1 2017. 42 funds tracked by Wall St. Rank hold LPCN as of Q2 2017.

  • TIAA CREF Investment Management reported no remaining Lipocine position as of Q2 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 3,006 Lipocine shares in Q2 2017, an estimated $199K.
  • TIAA CREF Investment Management first reported a position in Lipocine in Q2 2016 and held it in 4 quarters.
  • TIAA CREF Investment Management's Lipocine position peaked at $199K in Q1 2017.
  • 42 funds tracked by Wall St. Rank held Lipocine as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.